Colon-specific drug delivery systems based on cyclodextrin prodrugs: In vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates

World Journal of Gastroenterology

Volumn 11, Issue 47, 2005, Pages 7457-7460

  Zou, Mei Juan ^a   Cheng, Gang ^a   Okamoto, Hirokazu ^b   Hao, Xiu Hua ^a   An, Feng ^a   Cui, Fu De ^a   Danjo, Kazumi ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

5 Aminosalicylic acid; Colon specific; Cyclodextrin; In vivo

Indexed keywords

ALPHA CYCLODEXTRIN; ANTIINFLAMMATORY AGENT; BETA CYCLODEXTRIN; CYCLODEXTRIN; ESTER; GAMMA CYCLODEXTRIN; HYDROXYL GROUP; MESALAZINE; PRODRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CECUM; COLON; CONJUGATE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TISSUE LEVEL; DRUG URINE LEVEL; GASTROINTESTINAL TRACT; IN VIVO STUDY; MALE; NONHUMAN; RAT; SMALL INTESTINE; STOMACH;

EID: 31144474364     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i47.7457     Document Type: Article

References (19)

1. Schacht E, Gevaert A, Kenawy ER, Molly K, Verstraete W, Adriaensens P, Caleer R, Gelan J. Polymers for colon specific drug delivery. J Control Release 1996; 39: 327-338
2. Carceller E, Salas J, Merlos M, Giral M, Ferrando R, Escamilla I, Ramis J, Garcia-Rafanell J, Forn J. Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. J Med Chem 2001; 44: 3001-3013
3. Brown JP, McGarraugh GV, Parkinson TM, Wingard RE Jr, Onderdonk AB. A polymeric drug for treatment of inflammatory bowel disease. J Med Chem 1983; 26: 1300-1307
4. Milojevic S, Newton JM, Cummings JH, Gibson GR, Botham RL, Ring SG, Stockham M, Allwood MC. Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets. J Control Release 1996; 38: 85-94
5. Van den Mooter G, Maris B, Samyn C, Augustijns P, Kinget R. Use of azo polymers for colon-specific drug delivery. J Pharm Sci 1997; 86: 1321-1327
6. Khan MZ, Stedul HP, Kurjakovic N. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations. Drug Dev Ind Pharm 2000; 26: 549-554
7. Wilding IR, Hardy JG, Sparrow RA, Davis SS, Daly PB, English JR. In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy. Pharm Res 1992; 9: 1436-1441
8. Fukui E, Miyamura N, Uemura K, Kobayashi M. Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting. Int J Pharm 2000; 204: 7-15
9. Gupta VK, Beckert TE, Price JC. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int J Pharm 2001; 213: 83-91
10. Siew LF, Man SM, Newton JM, Basit AW. Amylose formulations for drug delivery to the colon: a comparison of two fermentation models to assess colonic targeting performance in vitro. Int J Pharm 2004; 273: 129-134
11. Zambito Y, Di Colo G. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery. J Pharm Pharm Sci 2003; 6: 274-281
12. Sinha VR, Kumria R. Polysaccharide matrices for microbially triggered drug delivery to the colon. Drug Dev Ind Pharm 2004; 30: 143-150
13. Jung YJ, Lee JS, Kim YM. Colon-specific prodrugs of 5-amino-salicylic acid: synthesis and in vitro/in vivo properties of acidic amino acid derivatives of 5-aminosalicylic acid. J Pharm Sci 2001; 90: 1767-1775
14. Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery. Int J Pharm 2001; 224: 19-38
15. Watts PJ, Illum L. Colonic drug delivery. Drug Dev Ind Pharm 1997; 23: 893-913
16. Chourasia MK, Jain SK. Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci 2003; 6: 33-66
17. Zou M, Okamoto H, Cheng G, Hao X, Sun J, Cui F, Danjo K. Synthesis and properties of polysaccharide prodrugs of 5-aminosalicylic acid as potential colon-specific delivery systems. Eur J Pharm Biopharm 2005; 59: 155-160
18. Chungi VS, Rekhi GS, Shargel L. A simple and rapid liquid chromatographic method for the determination of major metabolites of sulfasalazine in biological fluids. J Pharm Sci 1989; 78: 235-238
19. Hussain FN, Ajjan RA, Moustafa M, Anderson JC, Riley SA. Simple method for the determination of 5-aminosalicylic and N-acetyl-5-aminosalicylic acid in rectal tissue biopsies. J Chromatogr B Biomed Sci Appl 1998; 716: 257-266